Navigation Links
Radyalis Announces Next Generation Of Monte Carlo Proton Therapy Planning For Advanced Radiation Cancer Treatment
Date:7/18/2014

AUSTIN, Texas, July 18, 2014 /PRNewswire-iReach/ -- Radyalis, a leader in advanced particle therapy software, will be showcasing its high performance Monte Carlo dose calculation product for proton applications simultaneously with the 2014 American Association of Physics in Medicine (AAPM) annual meeting in Austin, TX.

Radyalis breakthroughs in large-scale optimization and high-performance computing, enables for the first time clinicians to utilize the high accuracy benefits of Monte Carlo at unprecedented speeds for proton therapy dose modeling. The Radyalis Monte Carlo engine fundamentally changes today's radiotherapy workflow as the most complex patient treatment plans can be evaluated for efficacy and biological safety with high confidence in a matter of minutes.

Radyalis technology combines new algorithmic and software architecture advances for very high parallel efficiency on customer's existing hardware including single and multiple node installations, clusters, and cloud platforms, for both Linux and Windows environments.  Radyalis software is highly portable and very flexible, and designed to be integrated via a customer API or into a treatment planner.

Without compromise, Radyalis Monte Carlo supports a robust set of features. All relevant physics are accurately modeled. Simulation of complex geometries, NIST materials, and multiple beams are fully supported. Radyalis provides sophisticated dosage statistics including particle distributions, variability, fluence, and linear energy transfer, further guiding the radiation physicist.

The Radyalis fast and accurate Monte Carlo dose calculator is a key enabler for next-generation treatment plan optimization, robust planning, quality assurance, and ultimately real-time adaptive planning.  The speed and accuracy of Radyalis' Monte Carlo product provides significant ROI advantages for equipment manufacturers, treatment centers, and research organizations.

ABOUT RADYALIS

Radyalis develops and markets high performance software for radiotherapy applications that enable next-generation treatment planning and patient workflow. Based in Austin, Texas, the Radyalis team collectively brings 60+ years of related research and development experience to the particle therapy arena with focus on ultra-fast and accurate scanning-beam proton applications with extensions to other particle therapy methods. Radyalis has deep collaborations with premier oncology research hospitals and is committed to fundamentally impacting the accuracy, productivity, and cost of treatment planning through the increased use of automation.

RELATED LINKS:

http://radyalis.com

Media Contact: David LaPotin, Radyalis, 512-333-1619, david.lapotin@radyalis.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Radyalis
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Richmond Private Equity Group announces joint venture with Taking You Forward Inc.
2. Depomed Announces District Court Order in ANDA Litigation
3. Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
4. JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
5. Fragile Kids Foundation Announces $125,000 Grant from the James M. Cox Foundation
6. BioLife Solutions Announces Manufacturing Agreement With Somahlution LLC
7. Encapsula NanoSciences Announces Release of Two New Products
8. Contract Research Organization WCCT Global Announces Huge Success in Large Phase I Clinical Research Program
9. Webcast Alert: Heska Announces Second Quarter 2014 Earnings Conference Call Webcast
10. CVS Caremark Announces New Clinical Affiliations with Four Major Health Care Providers
11. Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... 16, 2017 Transparency Market Research states ... Devices Market  held a huge share of 43% in 2015. ... frontrunners in the overall market, grabbing the undivided attention of ... across geographies, and strong product portfolio is expected to keep ... ...
(Date:1/16/2017)... , Jan. 16, 2017  Dovetail Genomics today announced ... and assembly service, which yields chromosome-scale genome assemblies. The ... a Dovetail-hosted workshop on Jan. 17 at the Plant ... San Diego . "We are thrilled ... launch of our Dovetail Hi-C offering," said Todd ...
(Date:1/16/2017)... 2017  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is pleased ... , CFA to its Board of Directors. He is ... Asset Management LLC . He is also the Chief ... investment advisory firm with over $1.5 billion under management. ... in security analysis and portfolio management. He began his ...
Breaking Medicine Technology:
(Date:1/15/2017)... ... January 15, 2017 , ... ... is a program that strives to better communities around the world by offering ... It also provides the opportunity for team members to become involved in a ...
(Date:1/15/2017)... ... January 15, 2017 , ... San Francisco Magazine recently ... Area counties for 2017. Almost 1,000 nominations were submitted and a little over ... Results were announced the magazine’s January 2017 issue . , Under the ...
(Date:1/14/2017)... ... January 14, 2017 , ... Healthy ... expanding line of activated charcoal products. With more and more people opting to ... products according to how they cater to specific needs. , Moody Zook focused ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... ... that raise blood sugar levels. Counting carbohydrates is as easy as checking the ... only nutrient that affects blood sugar levels. Despite being sugar-free, proteins can influence ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... ... Moody Zook has taken on the challenge of providing additional organic alternatives for ... During the launch of the brand’s new line of all-natural activated charcoal products, ...
Breaking Medicine News(10 mins):